Reservoir Venture Partners is a venture capital firm based in Ohio, established in 2001. The firm specializes in early-stage investments, focusing primarily on companies within the healthcare technology and information technology sectors, as well as manufacturing and energy industries. Founded by Chris Selland, Reservoir Venture Partners aims to support innovative firms by providing the necessary capital and expertise to foster growth and development in these critical sectors.
AxioMed LLC specializes in designing and developing disc replacement devices aimed at alleviating neck pain and restoring normal spinal functions for patients suffering from degenerative disc disease. Founded in 2001 and based in Malden, Massachusetts, the company was previously known as AxioMed Spine Corporation until its name change in 2014. AxioMed has developed the Freedom® Lumbar Disc and initiated clinical trials for its products, which are intended to improve the standard of care beyond traditional fusion and first-generation artificial discs. The company is led by CEO Patrick McBrayer and COO James Kuras, who oversee a team with extensive experience in spinal implants and engineering. They are supported by a Medical Advisory Panel of surgeons from prominent spine centers and universities. AxioMed's operations encompass product development, testing, clinical and regulatory affairs, and manufacturing, with ongoing projects focusing on cervical spine solutions.
Scale Computing
Series D in 2012
Scale Computing, Inc. specializes in edge computing, virtualization, and hyperconverged infrastructure solutions tailored for midsized companies. The company’s flagship product, the HC3 platform, consolidates servers, storage, and virtualization into a single, integrated system that simplifies management and enhances application performance. By leveraging self-healing and automation technologies, HC3 minimizes downtime and reduces the complexities associated with traditional IT infrastructure, such as separate virtualization and disaster recovery software. This approach allows organizations to improve application uptime while lowering overall costs. Founded in 2007 and headquartered in Indianapolis, Indiana, Scale Computing aims to enable clients to focus on application management rather than infrastructure concerns.
Juventas Therapeutics
Series B in 2012
Juventas Therapeutics, Inc. is a clinical-stage biotechnology company based in Cleveland, Ohio, that focuses on developing non-viral gene therapies aimed at repairing the body’s natural processes. Established in 2007, the company specializes in treating non-healing wounds associated with advanced peripheral artery disease. Its lead therapy, JVS-100, utilizes stromal cell-derived factor-1 (SDF-1), a naturally occurring signaling protein that helps recruit the body’s stem cells to promote tissue repair. Juventas has successfully transitioned its therapeutic platform from concept to mid-stage clinical trials, supported by various investors and non-dilutive grants from organizations such as the Ohio Third Frontier and the Cleveland Clinic. The company aims to address life-threatening diseases, particularly cardiovascular conditions and ischemic disorders, through its innovative regenerative therapies.
AxioMed
Series D in 2010
AxioMed LLC specializes in designing and developing disc replacement devices aimed at alleviating neck pain and restoring normal spinal functions for patients suffering from degenerative disc disease. Founded in 2001 and based in Malden, Massachusetts, the company was previously known as AxioMed Spine Corporation until its name change in 2014. AxioMed has developed the Freedom® Lumbar Disc and initiated clinical trials for its products, which are intended to improve the standard of care beyond traditional fusion and first-generation artificial discs. The company is led by CEO Patrick McBrayer and COO James Kuras, who oversee a team with extensive experience in spinal implants and engineering. They are supported by a Medical Advisory Panel of surgeons from prominent spine centers and universities. AxioMed's operations encompass product development, testing, clinical and regulatory affairs, and manufacturing, with ongoing projects focusing on cervical spine solutions.
PacketMotion
Series C in 2009
PacketMotion, Inc. specializes in developing security investigations, alerting, and reporting solutions that enable enterprises to monitor user activity within their networks. The company offers the PacketSentry appliance, designed to track user behavior on server and application platforms, as well as a virtual segmentation solution to assist with compliance to payment card industry data security standards. In addition to its core products, PacketMotion provides various services, including installation, training, and custom solutions. These offerings aim to enhance insider awareness, manage threats, support compliance reporting, protect sensitive data, and monitor network activity. The company primarily serves IT and security professionals in the United States and Canada and is headquartered in San Jose, California. Founded in 2002, PacketMotion continues to focus on delivering robust security solutions for enterprises.
Mork Process
Series A in 2008
Mork Process for use in the pharmaceutical sector designs and constructs customized clean-in-Place, sterilize-in-Place, and clean-out-of-place systems. These systems are made to provide cleaning cycles, reproducible and predictable cleaning, and reduced use of water and chemicals.
Imalux Corporation
Series C in 2007
Imalux Corporation, an Ohio medical device company, is positioned to become the worldwide leader in the commercializationPhoto of medical imaging equipment and devices based on its proprietary Optical Coherence Tomography (OCT) technology. The Company’s products provide real-time, high spatial resolution imaging at the point-of-care in a variety of medical applications. OCT is a new imaging modality for visualization of tissue microstructure, especially in anatomical areas with stratified tissue. It has the ability to detect near-surface tissue abnormalities indicative of disease, which established imaging modalities might not detect. Many diseases, including cancer, are associated with superficial tissue structure disruption. Today, there is no commercialized in vivo method to visualize this tissue structure alteration; clinicians must do a biopsy and an ex vivo histopathological review using a conventional microscope. Imalux OCT products can be used to visualize structural disruptions in vivo at the point of care.
Sypherlink
Series B in 2007
Sypherlink, Inc. is an information management software company based in Dublin, Ohio, founded in 2001. The company provides a suite of products designed to improve data handling and quality for organizations, government agencies, and systems integrators. Its flagship product, Harvester, automates the data discovery and mapping process, helping users identify available information and understand relationships between various data sources. Additionally, Sypherlink offers Exploratory Warehouse, which allows for data warehouse prototyping, and Integrity, which focuses on enhancing ongoing data quality processes. The Harvester Integrator component further supports data movement by enabling the extraction, transformation, and loading (ETL) of data into target applications.
iSqFt
Series C in 2006
iSqFt, operating under Construction Software Technologies, Inc., offers online bid solicitation and preconstruction management solutions tailored for general contractors, subcontractors, and suppliers in the United States. The company provides a private construction office that allows general contractors to share project plans, specifications, addenda, and related documents with subcontractors and suppliers. Additionally, its Internet Plan Room grants access to project information and bidding documents for publicly traded construction projects. iSqFt also features SupplyLink LEADS, which helps building product manufacturers generate and deliver leads through a network of construction plan rooms. Founded in 1993, iSqFt is headquartered in Cincinnati, Ohio.
Five Star Technologies
Venture Round in 2006
Five Star Technologies is a supplier of high-performance dispersions, inks and pastes used in displays, photovoltaics, and microelectronic packaging. Combining its patented hydrodynamic cavitation process with innovative chemistry, Five Star produces the ElectroSperseâ„¢ series of inks and pastes as well as a wide range of precision dispersions. The ElectroSperse line features a range of conductive pastes with exceptional printability, low firing temperatures, high levels of conductivity, strong adhesion to a variety of substrates, and RoHS compliance. ElectroSperse grades can be tailored for a range of processing techniques, including screen, gravure, extrusion and ink jet printing. Targeted applications include electrodes, interconnects, and linearization patterns for displays, photovoltaic front side contacts, and hybrid microcircuits.
FLX Micro
Venture Round in 2005
FLX Micro manufactures silicon carbide-based microsensors. The company develops its products through silicon carbide deposition and microfabrication technology platform. Its products are used in various applications, such as automotive, energy, environmental, and manufacturing. The company was formerly known as Fiberlead, Inc. FLX Micro, Inc. was founded in 2000 and is headquartered in Cleveland, Ohio.
Manta
Series D in 2005
Manta is an online platform dedicated to supporting small businesses by enhancing their visibility and facilitating connections within a large community. It provides various marketing services aimed at helping these businesses reach new customers. Key features include keyword research, content creation, and performance tracking, which collectively enable small businesses to improve their online presence and attract leads and sales. Manta serves as a vital resource for small businesses to grow and thrive in a competitive digital landscape.
Sypherlink
Series A in 2005
Sypherlink, Inc. is an information management software company based in Dublin, Ohio, founded in 2001. The company provides a suite of products designed to improve data handling and quality for organizations, government agencies, and systems integrators. Its flagship product, Harvester, automates the data discovery and mapping process, helping users identify available information and understand relationships between various data sources. Additionally, Sypherlink offers Exploratory Warehouse, which allows for data warehouse prototyping, and Integrity, which focuses on enhancing ongoing data quality processes. The Harvester Integrator component further supports data movement by enabling the extraction, transformation, and loading (ETL) of data into target applications.
Ventaira Pharmaceuticals
Series C in 2005
Ventaira Pharmaceuticals is an emerging specialty pharmaceutical company dedicated to the development of innovative inhalation products. The company employs its proprietary electrohydrodynamic aerosolization and formulation technologies to create new inhaled drugs. Among its key products are fentanyl, aimed at treating breakthrough pain, and salmeterol, used for asthma management. Ventaira Pharmaceuticals focuses on advancing its unique technologies to enhance drug delivery and improve treatment options for patients.
AxioMed
Series B in 2005
AxioMed LLC specializes in designing and developing disc replacement devices aimed at alleviating neck pain and restoring normal spinal functions for patients suffering from degenerative disc disease. Founded in 2001 and based in Malden, Massachusetts, the company was previously known as AxioMed Spine Corporation until its name change in 2014. AxioMed has developed the Freedom® Lumbar Disc and initiated clinical trials for its products, which are intended to improve the standard of care beyond traditional fusion and first-generation artificial discs. The company is led by CEO Patrick McBrayer and COO James Kuras, who oversee a team with extensive experience in spinal implants and engineering. They are supported by a Medical Advisory Panel of surgeons from prominent spine centers and universities. AxioMed's operations encompass product development, testing, clinical and regulatory affairs, and manufacturing, with ongoing projects focusing on cervical spine solutions.
Imalux Corporation
Series B in 2005
Imalux Corporation, an Ohio medical device company, is positioned to become the worldwide leader in the commercializationPhoto of medical imaging equipment and devices based on its proprietary Optical Coherence Tomography (OCT) technology. The Company’s products provide real-time, high spatial resolution imaging at the point-of-care in a variety of medical applications. OCT is a new imaging modality for visualization of tissue microstructure, especially in anatomical areas with stratified tissue. It has the ability to detect near-surface tissue abnormalities indicative of disease, which established imaging modalities might not detect. Many diseases, including cancer, are associated with superficial tissue structure disruption. Today, there is no commercialized in vivo method to visualize this tissue structure alteration; clinicians must do a biopsy and an ex vivo histopathological review using a conventional microscope. Imalux OCT products can be used to visualize structural disruptions in vivo at the point of care.
Imalux Corporation
Series A in 2003
Imalux Corporation, an Ohio medical device company, is positioned to become the worldwide leader in the commercializationPhoto of medical imaging equipment and devices based on its proprietary Optical Coherence Tomography (OCT) technology. The Company’s products provide real-time, high spatial resolution imaging at the point-of-care in a variety of medical applications. OCT is a new imaging modality for visualization of tissue microstructure, especially in anatomical areas with stratified tissue. It has the ability to detect near-surface tissue abnormalities indicative of disease, which established imaging modalities might not detect. Many diseases, including cancer, are associated with superficial tissue structure disruption. Today, there is no commercialized in vivo method to visualize this tissue structure alteration; clinicians must do a biopsy and an ex vivo histopathological review using a conventional microscope. Imalux OCT products can be used to visualize structural disruptions in vivo at the point of care.
AxioMed
Series A in 2003
AxioMed LLC specializes in designing and developing disc replacement devices aimed at alleviating neck pain and restoring normal spinal functions for patients suffering from degenerative disc disease. Founded in 2001 and based in Malden, Massachusetts, the company was previously known as AxioMed Spine Corporation until its name change in 2014. AxioMed has developed the Freedom® Lumbar Disc and initiated clinical trials for its products, which are intended to improve the standard of care beyond traditional fusion and first-generation artificial discs. The company is led by CEO Patrick McBrayer and COO James Kuras, who oversee a team with extensive experience in spinal implants and engineering. They are supported by a Medical Advisory Panel of surgeons from prominent spine centers and universities. AxioMed's operations encompass product development, testing, clinical and regulatory affairs, and manufacturing, with ongoing projects focusing on cervical spine solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.